Page last updated: 2024-11-06

protizinic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

protizinic acid: RN given refers to cpd without isomeric designation; NM refers to (+-)-isomer; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID71862
CHEMBL ID2105285
CHEBI ID32067
SCHEMBL ID25022
MeSH IDM0047778

Synonyms (42)

Synonym
protizinic acid
prothizinic acid
17190rp
7-methoxy-alpha,10-dimethylphenothiazine-2-acetic acid
protizinic acid (jan/inn)
13799-03-6
D01185
2-(7-methoxy-10-methylphenothiazin-2-yl)propanoic acid
54323-85-2
17190-rp
CHEMBL2105285
acido protizinico
unii-n40195utpi
acidum protizinicum [inn-latin]
phenothiazine-2-acetic acid, 7-methoxy-alpha,10-dimethyl-
acido protizinico [inn-spanish]
einecs 237-453-0
10h-phenothiazine-2-acetic acid, 7-methoxy-alpha,10-dimethyl-
protizinic acid [inn:dcf:jan]
n40195utpi ,
2-(7-methoxy-10-methyl-2-phenothiazinyl)propionic acid
acide protizinique
acidum protizinicum
pirocrid
acide protizinique [inn-french]
AKOS015913792
SCHEMBL25022
7-methoxy-.alpha.,10-dimethylphenothiazine-2-acetic acid
protizinic acid [mart.]
protizinic acid [mi]
protizinic acid [jan]
protizinic acid [who-dd]
protizinic acid [inn]
10h-phenothiazine-2-acetic acid, 7-methoxy-.alpha.,10-dimethyl-
protizinsaure
CHEBI:32067
FT-0699912
DTXSID20864444
Q27284520
protizinicacid
CS-0026045
HY-106555
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
organic molecular entityAny molecular entity that contains carbon.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (88.89)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (11.11)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.68

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.68 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index4.32 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.68)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials3 (30.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (10.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (60.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]